Proteinuria after kidney transplantation, relationship to allograft histology and survival

H. Amer, M. E. Fidler, M. Myslak, P. Morales, Walter K Kremers, T. S. Larson, Mark D Stegall, Fernando G Cosio

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Proteinuria is associated with reduced kidney allograft survival. Herein we assessed the association between proteinuria, graft histology and survival. The cohort included 613 kidney allograft recipients who had proteinuria (measured) and surveillance biopsies at 1-year posttransplant. Proteinuria >150 mg/day was detected in 276 patients (45%) and in 182 of these, proteinuria was below 500. In >84% of patients even low levels of proteinuria were associated with albuminuria. Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus. Eighty percent of patients with proteinuria >1500 mg/day had glomerular pathology on biopsy. However, lower levels of proteinuria were not associated with specific pathologies at 1 year. Compared to no sirolimus, sirolimus use was associated with higher prevalence of proteinuria (40% vs. 76%, p < 0.0001) and higher protein excretion (378 + 997 vs. 955 + 1986 mg/day, p < 0.0001). Proteinuria was associated with reduced graft survival (HR = 1.40, p = 0.001) independent of other risk factors including, glomerular pathology, graft function, recipient age and acute rejection. The predominant pathology in lost allografts (n = 57) was glomerular, particularly in patients with 1-year proteinuria >500. Thus, proteinuria, usually at low levels (<500 mg/day), is present in 45% of recipients at 1 year. However, and even low levels of proteinuria relate to poor graft survival. Proteinuria and glomerular pathology relate independently to survival.

Original languageEnglish (US)
Pages (from-to)2748-2756
Number of pages9
JournalAmerican Journal of Transplantation
Volume7
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Proteinuria
Kidney Transplantation
Allografts
Histology
Survival
Sirolimus
Pathology
Graft Survival
Kidney
Biopsy
Albuminuria
Transplants

Keywords

  • Glomerular disease
  • Graft survival
  • Pathology of renal transplantation
  • Prognostic factors
  • Proteinuria
  • Protocol biopsies

ASJC Scopus subject areas

  • Immunology

Cite this

Proteinuria after kidney transplantation, relationship to allograft histology and survival. / Amer, H.; Fidler, M. E.; Myslak, M.; Morales, P.; Kremers, Walter K; Larson, T. S.; Stegall, Mark D; Cosio, Fernando G.

In: American Journal of Transplantation, Vol. 7, No. 12, 12.2007, p. 2748-2756.

Research output: Contribution to journalArticle

Amer, H. ; Fidler, M. E. ; Myslak, M. ; Morales, P. ; Kremers, Walter K ; Larson, T. S. ; Stegall, Mark D ; Cosio, Fernando G. / Proteinuria after kidney transplantation, relationship to allograft histology and survival. In: American Journal of Transplantation. 2007 ; Vol. 7, No. 12. pp. 2748-2756.
@article{7e2ca7108a4b4b6db026f40ca1496cc7,
title = "Proteinuria after kidney transplantation, relationship to allograft histology and survival",
abstract = "Proteinuria is associated with reduced kidney allograft survival. Herein we assessed the association between proteinuria, graft histology and survival. The cohort included 613 kidney allograft recipients who had proteinuria (measured) and surveillance biopsies at 1-year posttransplant. Proteinuria >150 mg/day was detected in 276 patients (45{\%}) and in 182 of these, proteinuria was below 500. In >84{\%} of patients even low levels of proteinuria were associated with albuminuria. Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus. Eighty percent of patients with proteinuria >1500 mg/day had glomerular pathology on biopsy. However, lower levels of proteinuria were not associated with specific pathologies at 1 year. Compared to no sirolimus, sirolimus use was associated with higher prevalence of proteinuria (40{\%} vs. 76{\%}, p < 0.0001) and higher protein excretion (378 + 997 vs. 955 + 1986 mg/day, p < 0.0001). Proteinuria was associated with reduced graft survival (HR = 1.40, p = 0.001) independent of other risk factors including, glomerular pathology, graft function, recipient age and acute rejection. The predominant pathology in lost allografts (n = 57) was glomerular, particularly in patients with 1-year proteinuria >500. Thus, proteinuria, usually at low levels (<500 mg/day), is present in 45{\%} of recipients at 1 year. However, and even low levels of proteinuria relate to poor graft survival. Proteinuria and glomerular pathology relate independently to survival.",
keywords = "Glomerular disease, Graft survival, Pathology of renal transplantation, Prognostic factors, Proteinuria, Protocol biopsies",
author = "H. Amer and Fidler, {M. E.} and M. Myslak and P. Morales and Kremers, {Walter K} and Larson, {T. S.} and Stegall, {Mark D} and Cosio, {Fernando G}",
year = "2007",
month = "12",
doi = "10.1111/j.1600-6143.2007.02006.x",
language = "English (US)",
volume = "7",
pages = "2748--2756",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Proteinuria after kidney transplantation, relationship to allograft histology and survival

AU - Amer, H.

AU - Fidler, M. E.

AU - Myslak, M.

AU - Morales, P.

AU - Kremers, Walter K

AU - Larson, T. S.

AU - Stegall, Mark D

AU - Cosio, Fernando G

PY - 2007/12

Y1 - 2007/12

N2 - Proteinuria is associated with reduced kidney allograft survival. Herein we assessed the association between proteinuria, graft histology and survival. The cohort included 613 kidney allograft recipients who had proteinuria (measured) and surveillance biopsies at 1-year posttransplant. Proteinuria >150 mg/day was detected in 276 patients (45%) and in 182 of these, proteinuria was below 500. In >84% of patients even low levels of proteinuria were associated with albuminuria. Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus. Eighty percent of patients with proteinuria >1500 mg/day had glomerular pathology on biopsy. However, lower levels of proteinuria were not associated with specific pathologies at 1 year. Compared to no sirolimus, sirolimus use was associated with higher prevalence of proteinuria (40% vs. 76%, p < 0.0001) and higher protein excretion (378 + 997 vs. 955 + 1986 mg/day, p < 0.0001). Proteinuria was associated with reduced graft survival (HR = 1.40, p = 0.001) independent of other risk factors including, glomerular pathology, graft function, recipient age and acute rejection. The predominant pathology in lost allografts (n = 57) was glomerular, particularly in patients with 1-year proteinuria >500. Thus, proteinuria, usually at low levels (<500 mg/day), is present in 45% of recipients at 1 year. However, and even low levels of proteinuria relate to poor graft survival. Proteinuria and glomerular pathology relate independently to survival.

AB - Proteinuria is associated with reduced kidney allograft survival. Herein we assessed the association between proteinuria, graft histology and survival. The cohort included 613 kidney allograft recipients who had proteinuria (measured) and surveillance biopsies at 1-year posttransplant. Proteinuria >150 mg/day was detected in 276 patients (45%) and in 182 of these, proteinuria was below 500. In >84% of patients even low levels of proteinuria were associated with albuminuria. Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus. Eighty percent of patients with proteinuria >1500 mg/day had glomerular pathology on biopsy. However, lower levels of proteinuria were not associated with specific pathologies at 1 year. Compared to no sirolimus, sirolimus use was associated with higher prevalence of proteinuria (40% vs. 76%, p < 0.0001) and higher protein excretion (378 + 997 vs. 955 + 1986 mg/day, p < 0.0001). Proteinuria was associated with reduced graft survival (HR = 1.40, p = 0.001) independent of other risk factors including, glomerular pathology, graft function, recipient age and acute rejection. The predominant pathology in lost allografts (n = 57) was glomerular, particularly in patients with 1-year proteinuria >500. Thus, proteinuria, usually at low levels (<500 mg/day), is present in 45% of recipients at 1 year. However, and even low levels of proteinuria relate to poor graft survival. Proteinuria and glomerular pathology relate independently to survival.

KW - Glomerular disease

KW - Graft survival

KW - Pathology of renal transplantation

KW - Prognostic factors

KW - Proteinuria

KW - Protocol biopsies

UR - http://www.scopus.com/inward/record.url?scp=35748938216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748938216&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2007.02006.x

DO - 10.1111/j.1600-6143.2007.02006.x

M3 - Article

VL - 7

SP - 2748

EP - 2756

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 12

ER -